Biodexa Pharmaceuticals Plc - BDRX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | No change | 14,809 | 43 | 0.0% | 0.0% | 1 | 0 | 0.0% | Q2 2026 | Aug 14, 2026 |
| StoneX Group Inc. | History | New | 12,499 | 8 | 0.0% | — | 2 | +12,499 | New | Q3 2026 | Nov 03, 2026 |
| Allied Private Wealth LLC | History | No change | 489 | 1 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q2 2026 | Jul 09, 2026 |
| GAMMA Investing LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -1,203 | -100.0% | Q3 2026 | Oct 08, 2026 |
| SBI Securities Co., Ltd. | History | Reduced | 19 | 0 | — | — | — | -10 | -34.48% | Q3 2026 | Oct 21, 2026 |
| Hilton Head Capital Partners, LLC | History | Closed out | 0 | 0 | — | — | — | -6 | -100.0% | Q3 2026 | Oct 23, 2026 |
| Caitong International Asset Management Co., Ltd | History | Reduced | 1 | 0 | — | — | — | -4 | -80.0% | Q3 2026 | Oct 29, 2026 |
| RHUMBLINE ADVISERS | History | No change | 3 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 11, 2026 |
| UBS Group AG | History | No change | 25 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |